2026

Regulatory Approvals

FDA Approves Talazoparib/Enzalutamide for HRR Gene-Altered Metastatic Prostate Cancer

Oct 26, 2026

FDA Approves Talazoparib/Enzalutamide for HRR Gene-Altered Metastatic Prostate Cancer CancerNetwork

Regulatory Approvals

FDA Approves Talazoparib/Enzalutamide in HRR-Mutated Prostate Cancer

Oct 26, 2026

FDA Approves Talazoparib/Enzalutamide in HRR-Mutated Prostate Cancer Targeted Oncology

Regulatory Approvals

FDA Approves Talazoparib With Enzalutamide for Certain Metastatic HRR-Mutated Prostate Cancers

Oct 26, 2026

FDA Approves Talazoparib With Enzalutamide for Certain Metastatic HRR-Mutated Prostate Cancers The ASCO Post

Credit Ratings

Higher equity holdings weigh on China Taiping’s capital as Fitch affirms ‘A-’ rating

Oct 26, 2026

Higher equity holdings weigh on China Taiping’s capital as Fitch affirms ‘A-’ rating (Re)in Asia

Credit Ratings

Fitch Diverges From South Africa’s Treasury on Debt Outlook

Oct 26, 2026

Fitch Diverges From South Africa’s Treasury on Debt Outlook Bloomberg.com

Business Economy Finance

Commodities Price Update: Crude Oil $90.83, Brent $98.32, Copper $6.24, Coal $104.75 — Nov 7, 2026 10:01 AM EST

Regulation

Supreme Court Weighs Federal Officer Liability as ICE Suits Loom

Regulation

Antitrust Challenge of Division III’s Athletic Scholarship Ban Could Draw Institutions Into Fray

Regulation

EPA Finalizes First-of-Its-Kind Air Quality Plan to Promote Clean Air and Facilitate Economic Growth in Maricopa County